Virus exposure and neurodegenerative disease risk across national biobanks
- PMID: 36669485
- PMCID: PMC10079561
- DOI: 10.1016/j.neuron.2022.12.029
Virus exposure and neurodegenerative disease risk across national biobanks
Abstract
With recent findings connecting the Epstein-Barr virus to an increased risk of multiple sclerosis and growing concerns regarding the neurological impact of the coronavirus pandemic, we examined potential links between viral exposures and neurodegenerative disease risk. Using time series data from FinnGen for discovery and cross-sectional data from the UK Biobank for replication, we identified 45 viral exposures significantly associated with increased risk of neurodegenerative disease and replicated 22 of these associations. The largest effect association was between viral encephalitis exposure and Alzheimer's disease. Influenza with pneumonia was significantly associated with five of the six neurodegenerative diseases studied. We also replicated the Epstein-Barr/multiple sclerosis association. Some of these exposures were associated with an increased risk of neurodegeneration up to 15 years after infection. As vaccines are currently available for some of the associated viruses, vaccination may be a way to reduce some risk of neurodegenerative disease.
Keywords: Alzheimer’s disease; Parkinson’s disease; amyotrophic lateral sclerosis; encephalitis; generalized dementia; influenza; multiple sclerosis; varicella-zoster; vascular dementia; viral exposure.
Published by Elsevier Inc.
Conflict of interest statement
Declaration of interests K.S.L., H.L.L., H.I., N.J., F.F., and M.A.N.’s participation in this project was part of a competitive contract awarded to Data Tecnica International LLC by the National Institutes of Health to support open science research. M.A.N. also currently serves on the scientific advisory board for Clover Therapeutics and is an advisor to Neuron23 Inc.
Figures
Comment in
-
Viral pathogens increase risk of neurodegenerative disease.Nat Rev Neurol. 2023 May;19(5):259-260. doi: 10.1038/s41582-023-00790-6. Nat Rev Neurol. 2023. PMID: 36864169 Free PMC article.
References
-
- Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, et al. (2022). Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375, 296–301. - PubMed
-
- Spudich S, and Nath A (2022). Nervous system consequences of COVID-19. Science 375, 267–269. - PubMed
-
- Ranjan R, Abhinay A, and Mishra M (2018). Can oral microbial infections be a risk factor for neurodegeneration? A review of the literature. Neurol. India 66, 344–351. - PubMed
-
- Kurki MI, Karjalainen J, Palta P, Sipilä TP, Kristiansson K, Donner K, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. (2022). FinnGen: Unique genetic insights from combining isolated population and national health register data. medRxiv, 2022.03.03.22271360.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
